Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center

BACKGROUND: Tyrosine kinase inhibitors (TKI) and immunotherapy improved survival in metastatic renal cell carcinoma (mRCC). Disparities in treatment access are present in healthcare systems globally. The aim of this study was to analyze survival outcomes of mRCC patients treated with first-line TKIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Leite, Luciana de M., Bergerot, Paulo G., Dettino, Aldo L. A., Augusto R., José, Zequi, Stenio de C., Formiga, Maria Nirvana da C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993945/
https://www.ncbi.nlm.nih.gov/pubmed/33621005
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993945/
https://www.ncbi.nlm.nih.gov/pubmed/33621005
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0443

Ejemplares similares